Dr. Laura Marie Periman , MD
Ophthalmology • Seattle, WA
100 West Harrison Street, North Tower, Suite 360
Seattle, WA 98119
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on May 4, 2007; this date does not establish years in practice.
-
Published CMS data list 85 Original Medicare Part B services in 2020.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020. Published rows only; this is not a quality measure.
-
Published Part B service records, 2020:
- 83861 — Microfluid analysis of tears: 30 service units.
- 83516 — Analysis of substance using immunoassay technique, multiple step method: 26 service units.
- 92285 — Photography of content of eyes: 17 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2019 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2020). CPT notice
See all 4 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 97 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Xdemvy (Lotilaner) — 36 prescription fills, including refills.
- Miebo (Perfluorohexyloctane/Pf) — 24 prescription fills, including refills.
- Tyrvaya (Varenicline Tartrate) — 15 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 5 records in the table · Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 85% of clinicians listed under Ophthalmology in Seattle, WA (2024, 103 clinicians with data). Median for this group: 568. Middle half: 215 to 1,157.
Fewer Part D prescriptions than 85% of clinicians listed under Ophthalmology in Washington (2024, 356 clinicians with data). Median for this group: 711. Middle half: 263 to 1,536.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 305 in 2017 to 85 in 2020.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2017–2020.
Practice Location & Contact Primary Location
100 West Harrison Street, North Tower
Suite 360
Seattle, WA 98119
What Public CMS Data Show
Ophthalmology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
17 people with Original Medicare in 2020
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2020.
Medicare-allowed amount
About $2,816 in 2020
The total amount Medicare approved for these services in 2020. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020.
Paid by Medicare
About $1,992 in 2020
The part of the Medicare-allowed amount that Medicare itself paid in 2020, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020.
30-day fills
132 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$110,006 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $321,980.86 across 280 records.
By nature of payment (3 largest of 5)
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $186,196.04 across 31 records.
- Consulting Fee: $86,812.50 across 24 records.
- Compensation for serving as faculty or as a speaker for a medical education program: $21,340.00 across 7 records.
Reporting-company totals (3 largest of 17)
- Tarsus Pharmaceuticals, Inc.: $103,399.97 across 85 records.
- Mallinckrodt Hospital Products Inc.: $78,629.37 across 53 records.
- Alcon Vision LLC: $63,982.39 across 48 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2007
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Can order Medicare-covered services
CMS lists Dr. Periman as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Seattle and Washington
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 85% of clinicians listed under Ophthalmology in Seattle, WA (2024, 103 clinicians with data). Median for this group: 568. Middle half: 215 to 1,157.
Fewer Part D prescriptions than 85% of clinicians listed under Ophthalmology in Washington (2024, 356 clinicians with data). Median for this group: 711. Middle half: 263 to 1,536.
Part D drug cost
A higher Part D drug cost than 70% of clinicians listed under Ophthalmology in Seattle, WA (2024, 103 clinicians with data). Median for this group: $37,260. Middle half: $7,398 to $110,445.
A higher Part D drug cost than 65% of clinicians listed under Ophthalmology in Washington (2024, 356 clinicians with data). Median for this group: $37,281. Middle half: $8,559 to $140,934.
Medicare Part B
Comparisons use 2024 data. The latest CMS data for Dr. Periman are from 2020.
150 active clinicians are listed under Ophthalmology with a practice address in Seattle, WA (526 in Washington).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Seattle
2.7% of these 150 clinicians have the CMS telehealth indicator.
67.3% of these 150 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 72% from 305 in 2017 to 85 in 2020.
- 2017: 305
- 2018: 282
- 2019: 190
- 2020: 85
-
Medicare-allowed amount
Medicare-allowed amount decreased 75% from $11,462 in 2017 to $2,816 in 2020.
- 2017: $11,462
- 2018: $9,721
- 2019: $6,272
- 2020: $2,816
-
Paid by Medicare
Paid by Medicare decreased 79% from $9,658 in 2017 to $1,992 in 2020.
- 2017: $9,658
- 2018: $8,364
- 2019: $5,471
- 2020: $1,992
-
Medicare Part D prescriptions
Medicare Part D prescriptions varied from year to year: 101 in 2020 and 97 in 2024.
- 2020: 101
- 2021: 52
- 2022: 39
- 2023: 75
- 2024: 97
-
30-day fills
30-day fills varied from year to year: 138 in 2020 and 132 in 2024.
- 2020: 138
- 2021: 69
- 2022: 48
- 2023: 104
- 2024: 132
-
Part D drug cost
Part D drug cost increased 68% from $65,531 in 2020 to $110,006 in 2024.
- 2020: $65,531
- 2021: $40,937
- 2022: $28,858
- 2023: $73,599
- 2024: $110,006
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 57% from $205,520.59 in 2021 to $321,980.86 in 2025.
- 2021: $205,520.59
- 2022: $295,657.48
- 2023: $194,700.41
- 2024: $355,273.51
- 2025: $321,980.86
Sources: CMS Medicare Physician & Other Practitioners (2020), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 280 records totaling $321,980.86.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Mallinckrodt Hospital Products Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
ACTHAR | General | $13,800.00 |
| Mallinckrodt Hospital Products Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
ACTHAR | General | $13,800.00 |
| Mallinckrodt Hospital Products Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
ACTHAR | General | $13,800.00 |
| Alcon Vision LLC |
Consulting Fee
Cash or cash equivalent
|
TRYPTYR | General | $13,000.00 |
| Mallinckrodt Hospital Products Inc. |
Consulting Fee
Cash or cash equivalent
|
ACTHAR | General | $12,825.00 |
| Tarsus Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
XDEMVY | General | $10,695.00 |
| Alcon Vision LLC |
Consulting Fee
Cash or cash equivalent
|
TRYPTYR | General | $10,000.00 |
| ABBVIE INC. |
Consulting Fee
Cash or cash equivalent
|
DURYSTA | General | $9,675.00 |
| Tarsus Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
XDEMVY | General | $8,370.00 |
| Tarsus Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
XDEMVY | General | $8,370.00 |
| Tarsus Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
XDEMVY | General | $8,370.00 |
| Tarsus Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
XDEMVY | General | $8,370.00 |
| Tarsus Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
XDEMVY | General | $8,370.00 |
| Tarsus Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
XDEMVY | General | $8,370.00 |
| Mallinckrodt Hospital Products Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
ACTHAR | General | $8,280.00 |
| Lumenis BE inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
M22 | General | $7,481.04 |
| Bausch & Lomb Americas Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
BLINK NUTRITEARS | General | $6,800.00 |
| Alcon Vision LLC |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
TRYPTYR | General | $6,500.00 |
| Alcon Research LLC |
Consulting Fee
Cash or cash equivalent
|
TRYPTYR | General | $6,000.00 |
| Tarsus Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
XDEMVY | General | $5,580.00 |
| Alcon Vision LLC |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
TRYPTYR | General | $5,500.00 |
| Mallinckrodt Hospital Products Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
ACTHAR | General | $4,600.00 |
| Bausch & Lomb Americas Inc. |
Compensation for serving as faculty or as a speaker for a medical education program
Cash or cash equivalent
|
MIEBO | General | $3,850.00 |
| Tarsus Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
XDEMVY | General | $3,720.00 |
| Tarsus Pharmaceuticals, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
XDEMVY | General | $3,720.00 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2019 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2020; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
83861
Microfluid analysis of tears
|
30 | 14 | $45.00 | $22.03 |
|
83516
Analysis of substance using immunoassay technique, multiple step method
|
26 | 13 | $28.50 | $11.30 |
|
92285
Photography of content of eyes
|
17 | 13 | $51.40 | $25.40 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
12 | 11 | $240.86 | $119.09 |
Source: CMS Part B by Provider and Service, 2020; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Xdemvy | Lotilaner | 36 | 1,716 | $65,136.82 | 29 |
| Miebo | Perfluorohexyloctane/Pf | 24 | 720 | $18,029.57 | 13 |
| Tyrvaya | Varenicline Tartrate | 15 | 450 | $9,522.56 | — |
| Xiidra | Lifitegrast | 11 | 750 | $16,808.76 | — |
| Loteprednol Etabonate | Loteprednol Etabonate | 11 | 125 | $507.88 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2023-04-19NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
NUCC Taxonomy Code: 207WX0120X
An ophthalmologist who specializes in diseases of the cornea, sclera, eyelids, conjunctiva, and anterior segment of the eye.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSSources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 100 WEST HARRISON STREET, NORTH TOWER, SUITE 360, SEATTLE, WA 98119 (Tel: 2063470821)
Ophthalmology (license number reported to NPPES: WA MD00039796)
Registered at 320 W GALER ST STE 201, SEATTLE, WA 981193065 (Tel: 2063470821)
NPI status registered as active in NPPES database
Registered at 16150 NE 85TH ST STE 206, REDMOND EYE CLINIC, REDMOND, WA 980523543 (Tel: 4258853574)
Registered at 623 W HIGHLAND DR, SEATTLE, WA 981193446 (Tel: 2062822716)
Recorded as LAURA PERIMAN, MD
Ophthalmology (license number reported to NPPES: WA MD00039796)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Ophthalmology Specialists in Seattle
- Dr. Janet Chieh, MD
- Dr. Kaidi Wang, MD
- Dr. Jeannette Stallworth, MD
- Dr. Christina Lieu, MD
- Dr. Aaron Weingeist, MD
- Dr. Harry Geggel, MD
Mailing Address
623 W Highland Dr
Seattle, WA 981193446
Phone: 2062349846